Page last updated: 2024-08-05 11:55:30
monomethoxyflavanone
Any methoxyflavanone that is flavanone substituted by a methoxy group.
ChEBI ID: 38738
Members (9)
| Member | Definition | Role |
|---|---|---|
| hesperetin | A trihydroxyflavanone having the three hydroxy gropus located at the 3'-, 5- and 7-positions and an additional methoxy substituent at the 4'-position. | hesperetin |
| hesperidin | A disaccharide derivative that consists of hesperetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. | hesperidin |
| homoeriodictyol | A trihydroxyflavanone that consists of 3'-methoxyflavanone in which the three hydroxy substituents are located at positions 4', 5, and 7. | homoeriodictyol |
| isosakuranetin | A dihydroxyflavanone that is flavanone substituted by hydroxy groups at positions 5 and 7 and a methoxy group at position 4' (the 2S stereoisomer). | 4'-methoxy-5,7-dihydroxyflavanone |
| kurarinol | A trihydroxyflavanone that is (2S)-flavanone substituted by hydroxy groups at positions 7, 2' and 4' , a methoxy group at position 5 and a (2S)-5-hydroxy-5-methyl-2-(prop-1-en-2-yl)hexyl group at position 8 respectively. | kurarinol |
| leachianone a | A trihydroxyflavanone that is (2S)-flavanone substituted by a lavandulyl group at position 8, hydroxy groups at positions 5, 7 and 4' and a methoxy group at position 2'. Isolated from the roots of Sophora flavescens and Sophora leachiana, it exhibits antineoplastic and antimalarial activity. | leachianone A |
| matteucinol | A dihydroxyflavanone that is (2S)-flavanone with hydroxy groups at positions 5 and 7, methyl groups at positions 6 and 8 and a methoxy group at position 4'. | matteucinol |
| pinostrobin | A monohydroxyflavanone that is (2S)-flavanone substituted by a hydroxy group at position 5 and a methoxy group at position 7 respectively. | pinostrobin |
| sakuranetin | A flavonoid phytoalexin that is (S)-naringenin in which the hydroxy group at position 7 is replaced by a methoxy group. | sakuranetin |
Research
Studies (2,018)
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 133 (6.59) | 18.7374 |
| 1990's | 107 (5.30) | 18.2507 |
| 2000's | 345 (17.10) | 29.6817 |
| 2010's | 926 (45.89) | 24.3611 |
| 2020's | 507 (25.12) | 2.80 |
Study Types
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 138 (5.21%) | 5.53% |
| Reviews | 118 (4.46%) | 6.00% |
| Case Studies | 7 (0.26%) | 4.05% |
| Observational | 7 (0.26%) | 0.25% |
| Other | 2,377 (89.80%) | 84.16% |